News: $MRMD MariMed, Inc. Reports 2018 Fourth Quarter and Year End Results; Strong Revenue and EBITDA Growth
Fourth Q uarter 2018: 118% Year-Over-Year Revenue Growth F iscal 2018: 95% Revenue Year-Over-Year Growth ; Adjusted EBITDA up 53 % S trategic I nvestments Position M ariMed for D ynamic G rowth in Cannabis and Hemp CBD NORWOOD, April 17, 20...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.